{"database": "openregs", "table": "documents", "rows": [["FDA-2011-D-0436-0001", "FDA", "FDA-2011-D-0436", "Draft Guidance on Q11 Development and Manufacture of Drug Substances; Availability: International Conference on Harmonisation", "Notice", "Notice of Availability", "2011-06-29T04:00:00Z", 2011, 6, "2011-06-29T04:00:00Z", "2011-09-02T03:59:59Z", "2011-06-29T16:56:50Z", "2011-16255", 0, 0, "0900006480eb650e"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2011-D-0436-0001"], "units": {}, "query_ms": 78.9027270511724, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}